India now hosts over 150 such Healthcare and Life Sciences GCCs including R&D centers, Global Business Services, Shared Services, and Centres of Excellence employing more than three lakh professionals ...

India is seeking enhanced collaboration with Switzerland in research, biotechnology, and pharmaceuticals. This move aims to ...

Hyderabad: India's pharmaceutical industry is expected to remain anchored in generics and biosimilars through 2030, even as ...

With the US accounting for nearly 35% of India’s overall pharma shipments of over $30 billion in FY24-25, the move is expected to bolster growth prospects and pipeline visibility. A potential India-US ...

Natco Pharma shares gained 12% to Rs 918 in the current session against the previous close of Rs 822.10.

NEW DELHI (Reuters) -Some Indian pharmaceutical firms failed to follow rules that every batch of medicinal ingredients is tested, the country's drug regulator said on Wednesday, after deaths in the ...

Feb 10 (Reuters) - Indian ‌drugmaker ​Lupin said ‌on Tuesday it has ​settled a patent infringement dispute ‍with Japan's ...

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping pharmaceutical quality and compliance—forcing manufacturers to rethink oversight, ...

Sanofi has expanded its Hyderabad Global Capability Centre, raising capacity to 4,500 employees and deepening India's role in global pharma operations, AI, data science and innovation ...

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

NEW DELHI, Oct 14 (Reuters) - Indian authorities have accused Balaji Amines (BAMN.NS), opens new tab of producing pharmaceutical-grade propylene glycol without a drug manufacturing licence, after some ...